Evidence map›Paper›PMID 34163837›Full record

ArticleChemical science2021

Anticancer gold(iii)-bisphosphine complex alters the mitochondrial electron transport chain to induce

Jong Hyun Kim, Samuel Ofori, Sean Parkin, Hemendra Vekaria, Patrick G Sullivan, Samuel G Awuah

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Frontiers in chemistry · 2025
    Article
  14. A gold-based inhibitor of oxidative phosphorylation is effective against triple negative breast cancer.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Jong Hyun KimDepartment of Chemistry, University of Kentucky Lexington KY 40506 USA awuah@uky.edu.ORCID https://orcid.org/0000-0002-0294-4625
Samuel OforiDepartment of Chemistry, University of Kentucky Lexington KY 40506 USA awuah@uky.edu.
Sean ParkinDepartment of Chemistry, University of Kentucky Lexington KY 40506 USA awuah@uky.edu.ORCID https://orcid.org/0000-0001-5777-3918
Hemendra VekariaSpinal Cord and Brain Injury Research Center, University of Kentucky USA.
Patrick G SullivanSpinal Cord and Brain Injury Research Center, University of Kentucky USA.
Samuel G AwuahDepartment of Chemistry, University of Kentucky Lexington KY 40506 USA awuah@uky.edu.ORCID https://orcid.org/0000-0003-4947-7283
University of Kentucky · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Understanding the role of anti-apolipoprotein A-I antibodies in atherosclerotic cardiovascular diseaseP20GM130456 · NIGMS · UNIVERSITY OF KENTUCKY · PI M. Ashfaqul Alam · 2020 to 2026
$18.7M
Pilot Projects ProgramP30GM127211 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2018 to 2022
$5.7M
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBIR01NS112693 · NINDS · UNIVERSITY OF KENTUCKY · PI KILBAUGH, TODD JUSTEN, SULLIVAN, PATRICK G · 2020 to 2025
$3.3M
CSRD VA I01 CX001353NCI NIH HHS P30 CA177558NIGMS NIH HHS P20 GM130456NIGMS NIH HHS P30 GM127211NINDS NIH HHS R01 NS112693
6 · The paper itself

Abstract

Expanding the chemical diversity of metal complexes provides a robust platform to generate functional bioactive reagents. To access an excellent repository of metal-based compounds for probe/drug discovery, we capitalized on the rich chemistry of gold to create organometallic gold(iii) compounds by ligand tuning. We obtained novel organogold(iii) compounds bearing a 1,2-bis(diphenylphosphino)benzene ligand, providing structural diversity with optimal physiological stability. Biological evaluation of the lead compound

Identifiers

PMID34163837
PMCPMC8171344
OpenAlexW3158625065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.